Introduction: INTRABEAM x-ray sources (XRSs) have distinct output characteristics due to subtle variations between the ideal and manufactured products. The objective of this study is to intercompare 15 XRSs and to dosimetrically quantify the impact of manufacturing variations on the delivered dose.
| INTRODUCTION
The INTRABEAM ® (Carl Zeiss Meditec AG, Oberkochen, Germany)
x-ray source (XRS) is an innovative electronic brachytherapy device used for intraoperative radiation therapy (IORT) delivery in clinical trials such as the TARGeted Intraoperative radioTherapy (TARGIT) for breast cancer or the INTRAoperative radiotherapy for glioblastoma multiforme (INTRAGO) . 1 This XRS produces 40-kVp and 50-kVp energy x-rays at the tip of a needle-like probe, which may be used with a sterile catheter for kypho-IORT to treat spinal metastasis or with spherical applicators to treat the inner surface of the breast lumpectomy cavity or brain tumor bed. These rigid spherical applicators have 7.5-to 25.0-mm radiuses with 2.5-mm increments. After removing the tumor, an appropriately sized spherical applicator is placed in the tumor bed and secured into position using a pursestring suture. Radiation is delivered to the tissue surrounding the spherical applicator to treat neoplastic cells and reduce the risk of recurrence. 1 Although each INTRABEAM XRS has the same design, the output and the shape of the depth-dose curve (DDC) for each XRS can vary because of manufacturing variances in the thickness of the gold x-ray target and electron source. 2, 3 INTRABEAM system users commented on source-to-source variations using sample sizes of 2-4 XRSs, [3] [4] [5] but no report has estimated the dosimetric impact to the patient resulting from these variations. Armoogun et al. 5 presented a functional inter-source comparison of four photon radiosurgery system XRSs, the predecessor design to the current INTRABEAM 500. Their study used an in-house water phantom and a Physikalisch Technische Werkstaetten (PTW) model 23342 parallel-plate ionization chamber to acquire a DDC for these four XRSs. Given the small sample size and lack of measurement uncertainty analysis, no meaningful statistical analysis was performed.
Since the publication of the Armoogun et al. 5 The objective of this study is to perform an intercomparison of 15 INTRABEAM XRSs to understand output variations of the manufactured product and to dosimetrically characterize the impact that these variations have on the tumor bed dose. First, a parallel-plate ionization chamber was used to perform a calibration consistency check of the vendor-provided DDC. Once validated, the DDC was used to evaluate variations in the output at 5-, 10-, 20-, and 30-mm depths from the XRS, and variations in the shape of the DDCs were evaluated using D 3/5 , D 5/10 , D 10/20 , and D 20/30 depth-dose ratios (DDRs) .
| METHODS AND MATERIALS

2.A | Device description
The system consists of a mobile floor stand, which is a counterbalanced arm designed to support a miniature x-ray generation unit.
Radiation is generated when the mobile x-ray unit accelerates a beam of electrons from the gun, down a drift tube, and then toward a thin hemispherical gold target of 1-µm (0.001 mm) thickness. 6 At the base of the drift tube are steering coils, which oscillate the beam around the tube axis in a process called "dithering" in order to create a "nearly isotropic" output. 7, 8 High-voltage electronics and an internal radiation monitor, which tracks radiation output, are stored within the base of the XRS. An example of an INTRABEAM XRS is shown in Fig. 1 . The output characteristics, spectrum, and features of the INTRABEAM system have been described. [9] [10] [11] [12] 2.B | Calibration and specialized Zeiss water phantom Zeiss calibrates the INTRABEAM system using the setup published by Beatty et al. 11 Per this setup, a DDC is measured from the XRS for 3-to 45-mm depth in steps of 0.5 mm as shown in [ Fig. 2(A) ]. The depth from the XRS is denoted z and the dose-rate in water from the XRS _ D w z ð Þ is expressed as shown in Eq. 1.
The ionization charge Q(z) is collected for 1 minute with a PTW model 34013 (0.005 cm 3 ) parallel-plate ionization chamber. These readings are corrected for temperature T and pressure P differences of Germany (PTB, Germany). They noted the difficulties in modeling the parallel-plate ionization chamber and the significant-measurement uncertainties. Thus, it is estimated that K Q = 1 ± 0.025, but a value of unity is used for K Q in this study to be consistent with the recommendations of the vendor. 14 Lastly, the conversion factor from air-kerma to dose to water is K Ka!Dw ¼ 1:054, which is reported on the chamber calibration certificate.
To estimate the perturbation to the x-ray beam and dose fall-off, when a spherical applicator is attached to the x-ray probe, the output of the source is multiplied by an applicator transfer function ATF (z). For depth z ≥ radius of the spherical applicator, the ATF (z) is a ratio of the dose-rate to water with the spherical applicator attached _ D wÀA z ð Þ; over the dose-rate to water without the spherical applicator _ D w z ð Þ as shown in Eq. 2.
Using a quality-controlled standard INTRABEAM XRS, the manufacturer publishes a set of ATF tables for each spherical applicator as shown in Appendix A. The ATF tables are advantageous because the XRSs can be interchanged without the DDCs being remeasured. 12, 13 Several investigators have used the ATF tables to estimate the dose-rate and dose distribution in the vicinity of the spherical applicator. [15] [16] [17] Figure 3 illustrates the self-shielded water phantom provided by Zeiss for users to validate the factory calibration. In this phantom,
the INTRABEAM x-ray probe can be mounted within and positioned reproducibly with a reported accuracy of ± 0.1 mm on a three-dimensional translational stage. 11 Inside the water phantom are two fixed water-proof chamber covers, one is used for depthdose measurements and the other is used for isotropy. Both covers hold the PTW model 34013 parallel-plate ionization chamber. A DDC is generated when the probe tip is translated longitudinally away from the parallel-plate ionization chamber. This water phantom was used to perform a calibration consistency check by comparing the measured dose-rate (Gy/minute) in water against the V4.0 calibration file at 5-, 10-, 20-, and 30-mm depths from the XRS.
2.C | Treatment time and dose
For the INTRABEAM system, treatment planning is performed using a manufacturer-provided calibration DDC. 11, 18 This device is not characterized using either the AAPM TG-43 or AAPM TG-61 protocols. 2 Thus, the treatment time in minutes is calculated as shown in
The dose at depth z is calculated with Eq. 4.
In this study, we compute the dose at 5-mm and 10-mm depths from the spherical applicator surface as shown in [ Fig. 2(B) ].
Because the spherical applicators have a 7.5-to 25.0-mm radius, the z = the applicator radius plus the 5-mm or 10-mm depths.
For example, a 7.5-mm radius applicator would have z = 7.5 mm + 
2.D | The shape of the depth-dose curve (DDC)
The DDC of each XRS has a unique slope. The variability in slope is evaluated using the format D x=y , which is a ratio of dose-rate in Gy/minute at a depth x in mm divided by dose-rate in Gy/minute at a depth y in mm. In this study, we consider four different ratios: 
2.E | Uncertainty of measured dose
The mean positional deviation in measurement for a single XRS at a
The dose-rate in water at depth z is represented by _ D w z ð Þ; thus, the dosimeter readings more proximal and distal to the source can be
tively. The ± 0.1-mm chamber offset was chosen because it was consistent with the reported tolerance for the Zeiss water phantom. 13 In this study, the estimation and propagation of uncertainty followed the outline of the International Organization of Standardization (ISO) in their guide to the expression of uncertainty in measurement (GUM). The uncertainty in the measured dose σ for an XRS using the Zeiss method σ Zeiss k¼1 ð Þ can be expressed in Eq. 6.
The standard deviation (SD) of the mean σ rep is estimated from three chamber measurements. The chamber calibration factors (i.e., 
2.F | X-ray source (XRS) evaluation
The straightness of the probe influences the isotropy of the radiation field produced by the XRS. We evaluated the isotropy of an XRS with a fixed geometry attachment known as the photodiode array (PDA), which measures radiation output with five diodes. Deviations in output are corrected by fine-tuning the voltage applied to the steering coils during the dynamic offset check. 9 If the isotropy exceeds ± 6%, a mechanical hammer is used to straighten the probe. 
2.G | Statistical analyses
In this study, the normality of the continuous data was evaluated by the Shapiro-Wilk test 20 see Appendix B for more details. After normality conditions were satisfied, we reported dose with the minimum, maximum, and mean outputs; confidence interval (CI) (95%); SD, standard error (SE); coefficient of variation (CV); skewness; and kurtosis values. The CV is the percentage ratio between SD and mean value. In this study, the CV is calculated for the dose, doserate, and DDR. Additionally, we reported the mean of the DDCs, SD, SE as a function of depth for the 40-kVp and 50-kVp output. The consensus guidelines recommend reporting SD to two significant digits, SE to one significant digit, and percent differences (i.e., CV) to one decimal place. 21 The minimum, maximum, and mean values of the 40-kVp and 50-kVp DDRs are reported to one decimal place.
Lastly, dose-rate and dose values are reported to two decimal places.
| RESULTS
The dose-rate as a function of the depth around the XRS is characterized to commission a new source in the clinical treatment planning system. Figure 4 presents the output characteristics for 15 XRSs on a logarithmic scale for 40-kVp and 50-kVp energies. The dose gradient near the XRS is very steep; thus, the separation between the parallel-plate ionization chamber and x-ray source must be known to high accuracy. The reported accuracy of the Zeiss water phantom is ± 0.1 mm. 13 Using the DDCs, we considered the change in measured dose-rate for a ± 0.1 mm chamber offset at 5-, 10-, 20-, and 30-mm depths from the source and for 40-kVp and T A B L E 1 Comparison of the change in measured dose-rate for a ± 0.1-mm chamber offset using the DDC. The coefficient of variation (CV) is reported to one decimal place per consensus guidelines. 50-kVp energies. These results are summarized in Table 1 . At ≤ 5mm depths from the source, positional uncertainty of ± 0.1 mm can lead to > 5% deviations in measured dose-rate: 6.2% for 40 kVp and 5.8% for 50 kVp. At 5-, 10-, 20-, and 30-mm depths from the source while using the Zeiss method (k = 1), the uncertainty of measured dose was shown to be 6.3%, 3.6%, 2.4%, and 2.2%, respectively, in Table 2 . These uncertainty values were applicable to both the 40-kVp and 50-kVp energies. All measured values agreed with the calibration data within the uncertainty of the measured dose. Table 4 .
We observed that the CV of the DDRs generally decreased as depth increased.
Because our dataset satisfied the Shapiro-Wilk normality conditions as demonstrated in Appendix B, the mean dose-rate, SD, and SE were reported in Table 5 for When 20 Gy is prescribed to the surface of the applicator, the dose to the tumor bed (i.e., 5 mm and 10 mm from the applicator surface) will vary because of the shape of the DDC. Table 6 summarizes the mean, CV, and range of doses to the tumor bed for all 15 XRSs and 7.5-to 25-mm radius spherical applicators at 5-mm and 10-mm depths. The analysis was performed using the 50-kVp output States for the TARGIT clinical trial. 22 The CV was used to quantify the dosimetric impact where the CV increased as depth increased and as applicator size decreased. Manufacturing variations in the XRS produced a dosimetric effect of up to 2.1% and 2.5% at 5-mm and 10-mm depths from the 7.5-mm radius spherical applicator, respectively.
| DISCUSSION
The primary purpose of this study was to investigate source-to- Table 3 . Unlike previous studies, this study has a larger sample size of 15 XRSs and presents novel DDRs. While it is beyond the scope of this paper to speculate on the reasons for the observed differences, it has been previously suggested that the dose-rate differences are attributed to the variability in target size, and small changes in other x-ray generation structures (i.e., electron source). 3 
| CONCLUSION
The accuracy of the dose delivery influences both the benefits and the risks of radiotherapy. AAPM TG-167 requires that the impurities in radionuclides used for brachytherapy be limited to ≤ 5% dosimetric impact. This study demonstrated the variability in output characteristics of an XRS within a 10-mm depth from the applicator surface and that the maximum dosimetric effect of these variations was ≤ 2.5%. In general, the dosimetric impact of manufacturing variations increased as applicator size decreased and as the depth from the spherical applicator surface increased.
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